Company Details
|
|
Address
|
8000 Towers Crescent Dr., Suite 1300, Vienna, 22182
|
|
Telephone
|
646 239 1690
|
|
Fax
|
703 288 0070
|
Executives
|
|
Chairman
|
Eugene Bauer (3.30% holding)
|
|
Chief Executive
|
Andrew Pearlman (0.00% holding)
|
|
Finance Director
|
(0.00% holding)
|
|
Non-Exec Director
|
Joel Kanter (8.40% holding)
|
Main Shareholders
|
|
|
Leonard Steinberg: 13.7%
Alta California Partners III: 6.9%
Platinum-Montaur Life Sciences 1: 6.7%
Vision Opportunity Master Fund: 6.6%
|
Advisers
|
|
Nominated Adviser
|
Blomfield Corporate Finance
|
|
Nominated Broker
|
SVS Securities
|
|
Solicitors
|
Duane Morris
|
|
Auditors
|
Kost Forer Gabbay & Kasierer
|
|
Registrar
|
Capita Registrars
|
|
Commentary
|
|
Biopharmaceutical group
|
Company Data |
| Code |
MEDG |
| Sedol |
USU5824110 |
| Shares In Issue |
122.507 m |
| Indices
|
|
| Entry on AIM |
04/12/2007 |
| Interim Results |
n/a |
| Final Results |
n/a |
| Year End |
n/a |
| Accounts Due |
n/a |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
Yes |
| |
|
|
